PATENT CLAIM ANALYSIS

Application Number: 16046633
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["514", "317000"]

Abstract:
The present disclosure relates to tolperisone, or a pharmaceutically acceptable salt or hydrate thereof, with 10 ppm 2-methyl-1-(4-methylphenyl)-propenone (4-MMPPO) or less, methods of producing the same, as well as compositions related thereto. The disclosure further relates to methods of treating a subject with tolperisone under conditions that limit exposure of the subject to tolerable levels of 4-MMPPO.

Claim (Index 57):
The method of  claim 56 , wherein the oral dosage form is a tablet.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 95.0
- Lexical Diversity: 1.53333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12597664', '15068006', '15225182', '12597722', '10537434']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7522505814392204
- 35 USC 102 Novelty (BERT): 0.5367440821373559
- Combined Prediction Score: 0.730699931509034
- Mean Citation Score: 268.379786
- Max Citation Score: 331.5096
- Similarity Product: 193.2802743713379

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test